heiBIB: Seckinger, Anja

Seckinger, Anja PD Dr. med.Universität HeidelbergHeidelberg

Refine publication list

Year of publication

Type of Publication

List

Language

English (114)
German (9)

Co-author (Univ. of Heidelberg)

more ...

Co-author (external)

more ...

Publications in heiBIB

Hose, Dirk: Correction: Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma / Dirk Hose, Seemun Ray, Sina Rößler, Ulrich Thormann, Reinhard Schnettler, Kim de Veirman, Thaqif El … , 24 January 2025. - 1 S.
In: Journal of hematology & oncology, ISSN 1756-8722. 18(2025), Artikel-ID 11, Seite 1
DOI: 10.1186/s13045-025-01663-9
Hose, Dirk: Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma / Dirk Hose, Seemun Ray, Sina Rößler, Ulrich Thormann, Reinhard Schnettler, Kim de Veirman, Thaqif El … , 18 December 2024. - 20 S. : Illustrationen
In: Journal of hematology & oncology, ISSN 1756-8722. 17(2024), Artikel-ID 128, Seite 1-20
DOI: 10.1186/s13045-024-01636-4
Hummel, Manuela: Quantitative integrative survival prediction in multiple myeloma patients treated with bortezomib-based induction, high-dose therapy and autologous stem cell transplantation / Manuela Hummel; Thomas Hielscher; Martina Emde-Rajaratnam; Hans Salwender; Susanne Beck; Christof Sc… , July 10, 2024. - 12 S. : Illustrationen
In: JCO precision oncology, ISSN 2473-4284. 8(2024), Artikel-ID e2300613, Seite 1-12
DOI: 10.1200/PO.23.00613
Seckinger, Anja: Molecular long-term analysis of the GMMG-HD4 trial in multiple myeloma$patterns of Association of Chromosomal Aberrations with response and proliferation determining survival in selecting treatments in view of limited resources in low- and middle-income countries / Anja Seckinger, Hans Salwender, Hans Martin, Christof Scheid, Thomas Hielscher, Uta Bertsch, Manuela… , 11 June 2024. - 19 S. : Illustrationen
In: International journal of molecular sciences, ISSN 1422-0067. 25(2024), 12, Artikel-ID 6431, Seite 1-19
DOI: 10.3390/ijms25126431
Emde-Rajaratnam, Martina: RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma / Martina Emde-Rajaratnam, Susanne Beck, Vladimir Benes, Hans Salwender, Uta Bertsch, Christoph Scheid… , 15 November 2023. - 18 S. : Illustrationen
In: Frontiers in immunology, ISSN 1664-3224. 14(2023) vom: Nov., Artikel-ID 1286700, Seite 1-18
DOI: 10.3389/fimmu.2023.1286700
Köhrer, Sebastian: High-throughput electron tomography identifies centriole over-elongation as an early event in plasma cell disorders / Sebastian Köhrer, Tobias Dittrich, Martin Schorb, Niels Weinhold, Isabella Haberbosch, Mandy Börmel,… , 11 October 2023. - 11 S. : Illustrationen
In: Leukemia, ISSN 1476-5551. 37(2023), 12, Seite 2468-2478
DOI: 10.1038/s41375-023-02056-y
Maichl, Daniela: Identification of NOTCH-driven matrisome-associated genes as prognostic indicators of multiple myeloma patient survival / Daniela Simone Maichl, Julius Arthur Kirner, Susanne Beck, Wen-Hui Cheng, Melanie Krug, Martin Kuric… , 05 September 2023. - 6 S. : Illustrationen
In: Blood cancer journal, ISSN 2044-5385. 13(2023), Artikel-ID 134, Seite 1-6
DOI: 10.1038/s41408-023-00907-6
Mai, Elias K.: Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma / Elias K. Mai, Stefanie Huhn, Kaya Miah, Alexandra M. Poos, Christof Scheid, Katja C. Weisel, Uta Ber… , 04 January 2023. - 9 S.
In: Blood cancer journal, ISSN 2044-5385. 13(2023), 1, Artikel-ID 1, Seite 1-9
DOI: 10.1038/s41408-022-00772-9
Stroh, Jacob: MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma / Jacob Stroh, Anja Seckinger, Michael Heider, Martina Rudelius, Ruth Eichner, Markus Schick, Jolanta … , 18 January 2022. - 6 S.
In: Blood advances, ISSN 2473-9537. 6(2022), 2, Seite 515-520
DOI: 10.1182/bloodadvances.2021005532
Basset, Marco: Lenalidomide and dexamethasone in relapsed/refractory immunoglobulin light chain (AL) amyloidosis : results from a large cohort of patients with long follow-up / Marco Basset, Christoph R. Kimmich, Nicholas Schreck, Julia Krzykalla, Tobias Dittrich, Kaya Veelken… , 3 August 2021. - 14 S.
In: British journal of haematology, ISSN 1365-2141. 195(2021), 2, Seite 230-243
DOI: 10.1111/bjh.17685
Klein, Eva-Maria: Prognostic impact of serum free light chain ratio normalization in patients with multiple myeloma treated within the GMMG-MM5 trial / Eva-Maria Klein, Diana Tichy, Hans J. Salwender, Elias K. Mai, Jan Duerig, Katja C. Weisel, Axel Ben… , 28 September 2021. - 16 S.
In: Cancers, ISSN 2072-6694. 13(2021), 19, Artikel-ID 4856, Seite 1-16
DOI: 10.3390/cancers13194856
Khandanpour, Cyrus: Prevalence of the GFI1-36N SNP in multiple myeloma patients and its impact on the prognosis / Cyrus Khandanpour, Christine Eisfeld, Subbaiah Chary Nimmagadda, Marc S. Raab, Niels Weinhold, Anja … , 25 October 2021. - 8 S.
In: Frontiers in oncology, ISSN 2234-943X. 11(2021) vom: 25. Okt., Artikel-ID 757664, Seite 1-8
DOI: 10.3389/fonc.2021.757664
Tirier, Stephan Marius: Subclone-specific microenvironmental impact and drug response in refractory multiple myeloma revealed by single‐cell transcriptomics / Stephan M. Tirier, Jan-Philipp Mallm, Simon Steiger, Alexandra M. Poos, Mohamed H. S. Awwad, Nicola … , 29 November 2021. - 16 S.
In: Nature Communications, ISSN 2041-1723. 12(2021), Artikel-ID 6960, Seite 1-16
DOI: 10.1038/s41467-021-26951-z
Mai, Elias K.: Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age / Elias K. Mai, Kaya Miah, Uta Bertsch, Jan Dürig, Christof Scheid, Katja C. Weisel, Christina Kunz, M… , 2021. - 14 S.
In: Leukemia, ISSN 1476-5551. 35(2021), 3, Seite 809-822
DOI: 10.1038/s41375-020-0976-9
Bärtsch, Marc-Andrea: Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma / Marc-Andrea Baertsch, Elias K. Mai, Thomas Hielscher, Uta Bertsch, Hans J. Salwender, Markus Munder,… , 07 January 2021. - 10 S.
In: Blood cancer journal, ISSN 2044-5385. 11(2021), Artikel-ID 1, Seite 1-10
DOI: 10.1038/s41408-020-00390-3
Goldschmidt, Hartmut: Response-adapted lenalidomide maintenance in newly diagnosed myeloma : results from the phase III GMMG-MM5 trial / Hartmut Goldschmidt, Elias K. Mai, Jan Dürig, Christof Scheid, Katja C. Weisel, Christina Kunz, Uta … , 7 February 2020. - 13 S.
In: Leukemia, ISSN 1476-5551. 34(2020), 7, Seite 1853-1865
DOI: 10.1038/s41375-020-0724-1
Volpin, Valentina: CAMK1D triggers immune resistance of human tumor cells refractory to Anti-PD-L1 treatment / Valentina Volpin, Tillmann Michels, Antonio Sorrentino, Ayse N. Menevse, Gertrud Knoll, Madlen Ditz,… , July 14, 2020. - 17 S.
In: Cancer immunology research, ISSN 2326-6074. 8(2020), 9, Seite 1163-1179
DOI: 10.1158/2326-6066.CIR-19-0608
Malik, Rizwan: Quantitative efficacy and fate of mesenchymal stromal cells targeted to cardiac sites by radiofrequency catheter ablation / Rizwan Malik, Fabrice F. Darche, Rasmus Rivinius, Anja Seckinger, Ulf Krause, Michael Koenen, Dierk … , 2020. - 12 S.
In: Cell transplantation, ISSN 1555-3892. 29(2020) Artikel-Nummer 0963689720914236, 12 Seiten
DOI: 10.1177/0963689720914236
Hájek, Roman: Identification of patients with smouldering multiple myeloma at ultra-high risk of progression using serum parameters : the Czech Myeloma Group model / Roman Hájek, Viera Sandecka, Ivan Špička, Marc Raab, Hartmut Goldschmidt, Susanne Beck, Jiří Minařík… , 12 March 2020. - 9 S.
In: British journal of haematology, ISSN 1365-2141. 190(2020), 2, Seite 189-197
DOI: 10.1111/bjh.16572
Kimmich, Christoph: Daratumumab for systemic AL amyloidosis : prognostic factors and adverse outcome with nephrotic-range albuminuria / Christoph R. Kimmich, Tobias Terzer, Axel Benner, Tobias Dittrich, Kaya Veelken, Alexander Carpinte… , April 30, 2020. - 14 S.
In: Blood, ISSN 1528-0020. 135(2020), 18, Seite 1517-1530
DOI: 10.1182/blood.2019003633
Goldschmidt, Hartmut: Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma : the randomized GMMG phase III trial ReLApsE / Hartmut Goldschmidt, Marc-Andrea Baertsch, Jana Schlenzka, Natalia Becker, Christina Habermehl, Thom… , 21 July 2020. - 11 S.
In: Leukemia, ISSN 1476-5551. 35(2021), 4, Seite 1134-1144
DOI: 10.1038/s41375-020-0948-0
Merz, Maximilian: Cytogenetic subclone formation and evolution in progressive smoldering multiple myeloma / Maximilian Merz, Thomas Hielscher, David Schult, Elias K. Mai, Marc S. Raab, Jens Hillengass, Anja S… , [2020]. - 5 S. : Diagramme
In: Leukemia, ISSN 1476-5551. 34(2020), 4, Seite 1192-1196
DOI: 10.1038/s41375-019-0634-2
Boussac, Hugues de: Kinome expression profiling to target new therapeutic avenues in multiple myeloma / Hugues de Boussac, Angélique Bruyer, Michel Jourdan, Anke Maes, Nicolas Robert, Claire Gourzones, La… , 2020. - 12 S.
In: Haematologica, ISSN 1592-8721. 105(2020), 3, Seite 784-795
DOI: 10.3324/haematol.2018.208306
Emde-Rajaratnam, Martina: RNA-sequencing based assessment of targets, risk and long term survival for personalized treatment of multiple myeloma / Martina Emde, Susanne Beck, Vladimir Benes, Jerome Moreaux, PhD, Anja Seckinger, Dirk Hose, MD, 13 November 2019. - 2 S. : Illustrationen
In: Blood, ISSN 1528-0020. 134(2019), Supplement_1, Artikel-ID 1801, Seite 1-2
DOI: 10.1182/blood-2019-131159
Beck, Susanne: Prediction of malingant plasma cell biology related survival in AL-amyloidosis / Susanne Beck, Martina Emde, Jerome Moreaux, Anja Seckinger, Dirk Hose, 13 November 2019. - 3 S.
In: Blood, ISSN 1528-0020. 134(2019), Supplement_1, Artikel-ID 3078, Seite 1-3
DOI: 10.1182/blood-2019-131161
Stroh, Jacob: MCT1 as molecularly validated predictive marker for lenalidomide-maintenance therapy in multiple myeloma / Jacob Stroh, Anja Seckinger, Michael Heider, Ruth Eichner, Martina Emde, Hans Salwender, Uta Bertsch… , 13 November 2019. - 3 S.
In: Blood, ISSN 1528-0020. 134(2019), Supplement_1, Artikel-ID 3187, Seite 1-3
DOI: 10.1182/blood-2019-130734
Seckinger, Anja: Aberrantly expressed and normal plasma cell factors in pathogenesis and therapeutic intervention of malignant plasma cell diseases / vorgelegt von Dr. med. Anja Seckinger. -
Heidelberg, 2019. - 1 Band (verschiedene Seitenzählungen) : Illustrationen, Diagramme
Darche, Fabrice Fernand: Pacemaker cell characteristics of differentiated and HCN4-transduced human mesenchymal stem cells / Fabrice F. Darche, Rasmus Rivinius, Eva Köllensperger, Uwe Leimer, Günter Germann, Anja Seckinger, D… , 07 July 2019. - 16 S.
In: Life sciences, ISSN 1879-0631. 232(2019), Artikel-ID 116620, Seite 1-16
DOI: 10.1016/j.lfs.2019.116620
Merz, Maximilian: Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myeloma / Maximilian Merz, Thomas Hielscher, Elias Karl Mai, Anja Seckinger, Dirk Hose, Anna Jauch, Sandra Sau… , 27 August 2019. - 5 S.
In: Blood cancer journal, ISSN 2044-5385. 9(2019,9) Artikel-Nummer 71, 5 Seiten
DOI: 10.1038/s41408-019-0235-3
Weisel, Katja: Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone : results of the phase II PERSPECTIVE multiple myeloma trial / Katja C. Weisel, Christof Scheid, Manola Zago, Britta Besemer, Elias K. Mai, Mathias Haenel, Jan Due… , 08 April 2019. - 4 S.
In: Blood cancer journal, ISSN 2044-5385. 9(2019) Artikel-Nummer 45, 4 Seiten
DOI: 10.1038/s41408-019-0206-8
Posa, Francesca: Copresentation of BMP-6 and RGD ligands enhances cell adhesion and BMP-mediated signaling / Francesca Posa, Anna Luise Grab, Volker Martin, Dirk Hose, Anja Seckinger, Giorgio Mori, Slobodan Vu… , 15 December 2019. - 16 S.
In: Cells, ISSN 2073-4409. 8(2019,12) Artikel-Nummer 1646, 16 Seiten
DOI: 10.3390/cells8121646
Grab, Anna Luise: Hyaluronan hydrogels delivering BMP-6 for local targeting of malignant plasma cells and osteogenic differentiation of mesenchymal stromal cells / Anna Luise Grab, Anja Seckinger, Patrick Horn, Dirk Hose, Elisabetta Ada Cavalcanti-Adam, 11 July 2019. - 13 S.
In: Acta biomaterialia, ISSN 1878-7568. 96(2019), Seite 258-270
DOI: 10.1016/j.actbio.2019.07.018
Hose, Dirk: Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trial / Dirk Hose, Susanne Beck, Hans Salwender, Martina Emde, Uta Bertsch, Christina Kunz, Christoph Scheid… . -
London: BioMed Central, 09 Aug. 2019. - 1 Online-Ressource (12 Seiten)
Hose, Dirk: Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trial / Dirk Hose, Susanne Beck, Hans Salwender, Martina Emde, Uta Bertsch, Christina Kunz, Christoph Scheid… , 26 June 2019. - 12 S.
In: Journal of hematology & oncology, ISSN 1756-8722. 12(2019), Artikel-ID 65, Seite 1-12
DOI: 10.1186/s13045-019-0750-5
Khoo, Weng Hua: A niche-dependent myeloid transcriptome signature defines dormant myeloma cells / Weng Hua Khoo, Guy Ledergor, Assaf Weiner, Daniel L. Roden, Rachael L. Terry, Michelle M. McDonald, … , April 25, 2019. - 15 S.
In: Blood, ISSN 1528-0020. 134(2019), 1, Seite 30-43
DOI: 10.1182/blood.2018880930
Kriegsmann, Katharina: Cereblon-binding proteins expression levels correlate with hyperdiploidy in newly diagnosed multiple myeloma patients / Katharina Kriegsmann, Marc-Andrea Baertsch, Mohamed H. S. Awwad, Maximilian Merz, Dirk Hose, Anja Se… , 29 January 2019. - 10 S.
In: Blood cancer journal, ISSN 2044-5385. 9(2019), 2, Artikel-ID 13, Seite 1-10
DOI: 10.1038/s41408-019-0174-z
Seckinger, Anja: AL amyloidosis - pathogenesis and prognosis are determined by the amyloidogenic potential of the light chain and the molecular characteristics of malignant plasma cells / Anja Seckinger, Ute Hegenbart, Susanne Beck, Martina Emde, Tilmann Bochtler, Christoph Kimmich, Cars… , 29 November 2018. - 4 S.
In: Blood, ISSN 1528-0020. 132(2018), Supplement_1, Artikel-ID 187, Seite 1-4
DOI: 10.1182/blood-2018-187
Seckinger, Anja: Treatment response and long-term survival in multiple myeloma in the GMMG-HD4 trial : neither profit all molecular entities alike, nor are remissions to different regimen equal / Anja Seckinger, Hans Jürgen Salwender, MD, Hans Martin, MD, Christof Scheid, Thomas Hielscher, Uta B… , 29 November 2018. - 4 S.
In: Blood, ISSN 1528-0020. 132(2018), Supplement_1, Artikel-ID 4485, Seite 1-4
DOI: 10.1182/blood-2018-99-113284
Seckinger, Anja: Vorhabenbezeichnung: CLIOMMICS - clinically-applicable, omics-based assessment of survival, side effects, and targets in multiple myeloma : Schlussbericht : Laufzeit des Vorhabens: 01.09.2016-31.08.2018 / Zuwendungsempfänger: Ruprechts-Karls-Universität Heidelberg, Medizinischer Fakultät und Universitäts… . -
[Heidelberg]: Ruprechts-Karls-Universität Heidelberg, [2018?]. - 1 Online-Ressource (15 Seiten, 763,94 KB) : Diagramme
DOI: 10.2314/GBV:1663002541
Seckinger, Anja: Vorhabenbezeichnung: CLIOMMICS - clinically-applicable, omics-based assessment of survival, side effects, and targets in multiple myeloma : Schlussbericht : Laufzeit des Vorhabens: 01.09.2016-31.08.2018 / Zuwendungsempfänger: Ruprechts-Karls-Universität Heidelberg, Medizinischer Fakultät und Universitäts… . -
[Heidelberg]: Ruprechts-Karls-Universität Heidelberg, [2018?]. - 15 ungezählte Blätter : Diagramme
Merz, Maximilian: Cytogenetic abnormalities in monoclonal gammopathy of undetermined significance / Maximilian Merz, Thomas Hielscher, Korbinian Hoffmann, Anja Seckinger, Dirk Hose, Marc S. Raab, Jens… , 6 July 2018. - 3 S.
In: Leukemia, ISSN 1476-5551. 32(2018), 12, Seite 2717-2719
DOI: 10.1038/s41375-018-0202-1
Bochtler, Tilmann: Cytogenetic intraclonal heterogeneity of plasma cell dyscrasia in AL amyloidosis as compared with multiple myeloma / Tilmann Bochtler, Maximilian Merz, Thomas Hielscher, Martin Granzow, Korbinian Hoffmann, Alwin Kräme… , 2018. - 12 S.
In: Blood advances, ISSN 2473-9537. 2(2018), 20, Seite 2607-2618
DOI: 10.1182/bloodadvances.2018023200
Herviou, Laurie: PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs / Laurie Herviou, Alboukadel Kassambara, Stéphanie Boireau, Nicolas Robert, Guilhem Requirand, Carsten… , 03 October 2018. - 18 S. : Diagramme
In: Clinical epigenetics, ISSN 1868-7083. 10(2018), Artikel-ID 121, Seite 1-18
DOI: 10.1186/s13148-018-0554-4
Nair, Shiny: Antigen-mediated regulation in monoclonal gammopathies and myeloma / Shiny Nair, Joel Sng, Chandra Sekhar Boddupalli, Anja Seckinger, Marta Chesi, Mariateresa Fulcinit, … , April 19, 2018. - 14 S.
In: JCI insight, ISSN 2379-3708. 3(2018,8) Artikel-Nummer e98259, 14 Seiten
DOI: 10.1172/jci.insight.98259
Kriegsmann, Katharina: Quantification of number of CD38 sites on bone marrow plasma cells in patients with light chain amyloidosis and smoldering multiple myeloma / Katharina Kriegsmann, Tobias Dittrich, Brigitte Neuber, Mohamed H. S. Awwad, Ute Hegenbart, Hartmut … , 25 March 2018. - 10 S.
In: Cytometry, ISSN 1552-4957. 94(2018), 5, Seite 767-776
DOI: 10.1002/cyto.b.21636
Requirand, Guilhem: BrdU incorporation in multiparameter flow cytometry : a new cell cycle assessment approach in multiple myeloma / Guilhem Requirand, Nicolas Robert, Stéphanie Boireau, Laure Vincent, Anja Seckinger, Salaheddine Bou… , 2019. - 6 S.
In: Cytometry, ISSN 1552-4957. 96(2019), 3, Seite 209-214
DOI: 10.1002/cyto.b.21730
Bruyer, Angelique: DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells / Angelique Bruyer, Ken Maes, Laurie Herviou, Alboukadel Kassambara, Anja Seckinger, Guillaume Cartron… , 2 March 2018. - 12 S.
In: British journal of cancer, ISSN 1532-1827. 118(2018), 8, Seite 1062-1073
DOI: 10.1038/s41416-018-0025-x
Gu, Chunyan: Upregulation of FOXM1 in a subset of relapsed myeloma results in poor outcome / Chunyan Gu, Carol Holman, Ramakrishna Sompallae, Xuefang Jing, Michael Tomasson, Dirk Hose, Anja Sec… , 15 February 2018. - 5 S.
In: Blood cancer journal, ISSN 2044-5385. 8(2018,2) Artikel-Nummer 22, 5 Seiten
DOI: 10.1038/s41408-018-0060-0
Seckinger, Anja: CD38 as immunotherapeutic target in light chain amyloidosis and multiple myeloma : association with molecular entities, risk, survival, and mechanisms of upfront resistance / Anja Seckinger, Jens Hillengass, Martina Emde, Susanne Beck, Christoph Kimmich, Tobias Dittrich, Mic… , 20 July 2018. - 15$
In: Frontiers in immunology, ISSN 1664-3224. 9(2018), Artikel-ID 1676, Seite 1-15
DOI: 10.3389/fimmu.2018.01676
Mohr, Marcel: Quantification of plasma cell dynamics using mathematical modelling / Marcel Mohr, Dirk Hose, Anja Seckinger and Anna Marciniak-Czochra, 2018. - 15 S.
In: Royal Society Open Science, ISSN 2054-5703. 5(2018,1) Artikel-Nummer 170759, 15 Seiten
DOI: 10.1098/rsos.170759
Seckinger, Anja: Asymptomatic multiple myeloma : molecular background of progression and prognosis / Anja Seckinger, Anna Jauch, Martina Emde, Susanne Beck, Marcel Mohr, Martin Granzow, Thomas Hielsche… , February 2017. - 2 S.
In: Clinical lymphoma, myeloma & leukemia, ISSN 2152-2669. 17(2017), 1, Supplement vom: Feb., Seite e9-e10
DOI: 10.1016/j.clml.2017.03.016
Seckinger, Anja: CLIOMMICS - Clinically-applicable, omics-based assessment of survival, side effects, and targets in multiple myeloma : Schlussbericht : Laufzeit des Vorhabens: 01.09.2013-31.08.2016 / Zuwendungsempfänger: Ruprecht-Karls-Universität Heidelberg, Medizinische Fakultät und Universitätskl… . -
Heidelberg: Ruprecht-Karls-Universität Heidelberg, Medizinische Fakultät und Universitätsklinikum Heidelberg, Sektion Multiples Myelom, [2017?]. - 1 Online-Ressource (17 Seiten, 302,53 KB)
DOI: 10.2314/GBV:89050766X
Seckinger, Anja: CLIOMMICS - Clinically-applicable, omics-based assessment of survival, side effects, and targets in multiple myeloma : Schlussbericht : Laufzeit des Vorhabens: 01.09.2013-31.08.2016 / Zuwendungsempfänger: Ruprecht-Karls-Universität Heidelberg, Medizinische Fakultät und Universitätskl… . -
Heidelberg: Ruprecht-Karls-Universität Heidelberg, Medizinische Fakultät und Universitätsklinikum Heidelberg, Sektion Multiples Myelom, [2017?]. - 17 ungezählte Seiten
Kruppke, Benjamin: Drug release as a function of bioactivity, incubation regime, liquid, and initial load : release of bortezomib from calcium phosphate-containing silica/collagen xerogels / Benjamin Kruppke, Dirk Hose, Reinhard Schnettler, Anja Seckinger, Sina Rößler, Thomas Hanke, Sascha … , 2018. - 9 S.
In: Journal of biomedical materials research, ISSN 1552-4981. 106(2018), 3, Seite 1165-1173
DOI: 10.1002/jbm.b.33931
Khassawna, Thaqif el-: Osteocyte regulation of receptor activator of NF-[kappa]B ligand/osteoprotegerin in a sheep model of osteoporosis / Thaqif El Khassawna, Felix Merboth, Deeksha Malhan, Wolfgang Böcker, Diaa E. S. Daghma, Sabine Stoet… , August 2017. - 14 S.
In: The American journal of pathology, ISSN 1525-2191. 187(2017), 8, Seite 1686-1699
DOI: 10.1016/j.ajpath.2017.04.005
McDonald, Michelle M.: Inhibiting the osteocyte-specific protein sclerostin increases bone mass and fracture resistance in multiple myeloma / Michelle M. McDonald, Michaela R. Reagan, Scott E. Youlten, Sindhu T. Mohanty, Anja Seckinger, Racha… , May 17, 2017. - 13 S.
In: Blood, ISSN 1528-0020. 129(2017), 26, Seite 3452-3464
DOI: 10.1182/blood-2017-03-773341
Fan, Fengjuan: The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment / F. Fan, M. H. Bashari, E. Morelli, G. Tonon, S. Malvestiti, S. Vallet, M. Jarahian, A. Seckinger, D.… , July 2017. - 12 S.
In: Leukemia, ISSN 1476-5551. 31(2017), 7, Seite 1570-1581
DOI: 10.1038/leu.2016.358
Merz, Maximilian: Longitudinal fluorescence in situ hybridization reveals cytogenetic evolution in myeloma relapsing after autologous transplantation / Maximilian Merz, Anna Jauch, Thomas Hielscher, Elias K. Mai, Anja Seckinger, Dirk Hose, Uta Bertsch,… , May 11, 2017. - 7 S.
In: Haematologica, ISSN 1592-8721. 102(2017), 8, Seite 1432-1438
DOI: 10.3324/haematol.2017.168005
Schäfer, Julia: Cellular effect and efficacy of carfilzomib depends on cellular net concentration gradient / Julia Schäfer, Lukas Welti, Anja Seckinger, Jürgen Burhenne, Dirk Theile, Johanna Weiss, 12 May 2017. - 9 S.
In: Cancer chemotherapy and pharmacology, ISSN 1432-0843. 80(2017), 1, Seite 71-79
DOI: 10.1007/s00280-017-3335-4
Viziteu, Elena: RECQ1 helicase is involved in replication stress survival and drug resistance in multiple myeloma / E. Viziteu, B. Klein, J. Basbous, Y.-L. Lin, C. Hirtz, C. Gourzones, L. Tiers, A. Bruyer, L. Vincent… , 10 February 2017. - 10 S. : Illustrationen
In: Leukemia, ISSN 1476-5551. 31(2017), 10, Seite 2104-2113
DOI: 10.1038/leu.2017.54
Clemens, Jannick: Bortezomib, carfilzomib and ixazomib do not mediate relevant transporter‑based drug‑drug interactions / Jannick Clemens, Lukas Welti, Julia Schäfer, Anja Seckinger, Jürgen Burhenne, Dirk Theile and Johann… . - 8 S.
In: Oncology letters, ISSN 1792-1082. 14(2017), 3, S. 3185-3192
DOI: 10.3892/ol.2017.6560
Seckinger, Anja: Target expression, generation, preclinical activity, and pharmacokinetics of the BCMA-T cell bispecific antibody EM801 for multiple myeloma treatment / Anja Seckinger, Jose Antonio Delgado, Samuel Moser, Laura Moreno, Brigitte Neuber, Anna Grab, Susann… , 2017. - 15 S.
In: Cancer cell, ISSN 1878-3686. 31(2017), 3, Seite 396-410
DOI: 10.1016/j.ccell.2017.02.002
Schulze, Felix: A tissue-based approach to selection of reference genes for quantitative real-time PCR in a sheep osteoporosis model / Felix Schulze; Deeksha Malhan; Thaqif EL Khassawna; Christian Heiss; Anja Seckinger; Dirk Hose and A… . -
London ; Berlin ; Heidelberg: BioMed Central ; Springer, 30 Mai 2018. - 1 Online-Ressource (8 Seiten)
DOI: 10.1186/s12864-017-4356-4
Schmitt, Michael: Frequency of expression and generation of T-cell responses against antigens on multiple myeloma cells in patients included in the GMMG-MM5 trial / Michael Schmitt, Angela G. Hückelhoven, Michael Hundemer, Anita Schmitt, Susanne Lipp, Martina Emde,… , 2017. - 16 S.
In: OncoTarget, ISSN 1949-2553. 8(2017), 49, Seite 84847-84862
DOI: 10.18632/oncotarget.11215
Schulze, Felix: A tissue-based approach to selection of reference genes for quantitative real-time PCR in a sheep osteoporosis model / Felix Schulze, Deeksha Malhan, Thaqif El Khassawna, Christian Heiss, Anja Seckinger, Dirk Hose and A… , 2017, Dec 19. - 9 S.
In: BMC genomics, ISSN 1471-2164. 18(2017) Artikel-Nummer 975, 9 Seiten
DOI: 10.1186/s12864-017-4356-4
Granzow, Martin: Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect : first results from a genome-wide copy number array analysis / Martin Granzow, Ute Hegenbart, Katrin Hinderhofer, Dirk Hose, Anja Seckinger, Tilmann Bochtler, Kari… , July 2017. - 10 S.
In: Haematologica, ISSN 1592-8721. 102(2017), 7, Seite 1281-1290
DOI: 10.3324/haematol.2016.160721
Alaterre, Elina: CD24, CD27, CD36 and CD302 gene expression for outcome prediction in patients with multiple myeloma / Elina Alaterre, Sebastien Raimbault, Hartmut Goldschmidt, Salahedine Bouhya, Guilhem Requirand, Nico… , October 30, 2017. - 14 S.
In: OncoTarget, ISSN 1949-2553. 8(2017), 58, Seite 98931-98944
DOI: 10.18632/oncotarget.22131
Flores, Blanca: From bench to bedside : a view on bioinformatics pipelines / Blanca Flores, Dirk Hose, Anja Seckinger, Petra Knaup, Matthias Ganzinger, [2017]. - 4 S.
In: MEDINFO 2017. (2017), Seite 375-378
DOI: 10.3233/978-1-61499-830-3-375
Seckinger, Anja: Asymptomatic multiple myeloma : background of progression, evolution, and prognosis / Anja Seckinger, MD, Anna Jauch, PhD, Martina Emde, Susanne Beck, Marcel Mohr, Martin Granzow, PhD, … , 2 December 2016. - 3 S.
In: Blood, ISSN 1528-0020. 128(2016), 22, Artikel-ID 235, Seite 1-3
DOI: 10.1182/blood.V128.22.235.235
Schoenhals, Matthieu: Forced KLF4 expression increases the generation of mature plasma cells and uncovers a network linked with plasma cell stage / Matthieu Schoenhals, Michel Jourdan, Anja Seckinger, Véronique Pantesco, Dirk Hose, Alboukadel Kassa… , 21 Jun 2016. - 10 S.
In: Cell cycle, ISSN 1551-4005. 15(2016), 14, Seite 1919-1928
DOI: 10.1080/15384101.2016.1191709
Viziteu, Elena: Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myeloma / Elena Viziteu, Camille Grandmougin, Hartmut Goldschmidt, Anja Seckinger, Dirk Hose, Bernard Klein an… , 11 February 2016. - 5 S.
In: British journal of cancer, ISSN 1532-1827. 114(2016), 5, Seite 519-523
DOI: 10.1038/bjc.2016.20
Weinhold, Niels: Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma / Niels Weinhold, Desiree Kirn, Anja Seckinger, Thomas Hielscher, Martin Granzow, Uta Bertsch, Gerlind… , March 2016. - 4 S.
In: Haematologica, ISSN 1592-8721. 101(2016), 3, Seite e116-e119
DOI: 10.3324/haematol.2015.136929
Bochtler, Tilmann: Prognostic impact of cytogenetic aberrations in AL amyloidosis patients after high-dose melphalan : a long-term follow-up study / Tilmann Bochtler, Ute Hegenbart, Christina Kunz, Axel Benner, Christoph Kimmich, Anja Seckinger, Dir… , 2 June 2016. - 9 S.
In: Blood, ISSN 1528-0020. 128(2016), 4, Seite 594-602
DOI: 10.1182/blood-2015-10-676361
Dettmer, Susan: Proteasome inhibition correlates with intracellular bortezomib concentrations but not with antiproliferative effects after bolus treatment in myeloma cell lines / Susan Dettmer, Dirk Theile, Julia Schäfer, Anja Seckinger, Jürgen Burhenne, Johanna Weiss. - 11 S.
In: Naunyn-Schmiedeberg's archives of pharmacology, ISSN 1432-1912. 389(2016), 10, S. 1091-1101
DOI: 10.1007/s00210-016-1276-9
Merz, Maximilian: Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial / Maximilian Merz, Hans Salwender, Mathias Haenel, Elias K. Mai, Uta Bertsch, Christina Kunz, Thomas H… , December 2016. - 3 S.
In: Haematologica, ISSN 1592-8721. 101(2016), 12, Seite e485-e487
DOI: 10.3324/haematol.2016.151266
Merz, Maximilian: Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myeloma / Maximilian Merz, Thomas Hielscher, Anja Seckinger, Dirk Hose, Elias K. Mai, Marc S. Raab, Hartmut Go… , 10 August 2016. - 5 S.
In: American journal of hematology, ISSN 1096-8652. 91(2016), 11, Seite E473-E477
DOI: 10.1002/ajh.24533
Hose, Dirk: Clinical applicable multimodal prediction of survival in multiple myeloma (CAMPSIMM) : Schlussbericht : Laufzeit des Vorhabens: 01.02.2012-31.01.2015 / Zuwendungsempfänger: Ruprechts-Karls-Universität - Medizinische Fakultät und Universitätsklinikum He… . -
[Heidelberg]: [Universitätsklinikum Heidelberg, Sektion Multiples Myelom], [2015?]. - 13 ungezählte Seiten
Hose, Dirk: Clinical applicable multimodal prediction of survival in multiple myeloma (CAMPSIMM) : Schlussbericht : Laufzeit des Vorhabens: 01.02.2012-31.01.2015 / Zuwendungsempfänger: Ruprechts-Karls-Universität - Medizinische Fakultät und Universitätsklinikum He… . -
[Heidelberg]: [Universitätsklinikum Heidelberg, Sektion Multiples Myelom], [2015?]. - 1 Online-Ressource (13 Seiten, 216 KB)
DOI: 10.2314/GBV:879903279
Weinhold, Niels: The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells / Niels Weinhold, Tobias Meissner, David C Johnson, Anja Seckinger, Jérôme Moreaux, Asta Försti, Bowan… , 2015. - 4 S.
In: Haematologica, ISSN 1592-8721. 100(2015), 3, Seite e110-e113
DOI: 10.3324/haematol.2014.118786
Wei, Qiang: Regulation of integrin and growth factor signaling in biomaterials for osteodifferentiation / Qiang Wei, Theresa L.M. Pohl, Anja Seckinger, Joachim P. Spatz and Elisabetta A. Cavalcanti-Adam, 2015 May 13. - 11 S.
In: Beilstein journal of organic chemistry, ISSN 1860-5397. 11(2015), Seite 773-783
DOI: 10.3762/bjoc.11.87
Cowan, Graeme: Massive parallel IGHV gene sequencing reveals a germinal center pathway in origins of human multiple myeloma / Graeme Cowan, Nicola J. Weston-Bell, Dean Bryant, Anja Seckinger, Dirk Hose, Niklas Zojer, Surinder … , April 10, 2015. - 12 S.
In: OncoTarget, ISSN 1949-2553. 6(2015), 15, Seite 13229-13240
DOI: 10.18632/oncotarget.3644
Maes, Ken: In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma / Ken Maes, Eva De Smedt, Alboukadel Kassambara, Dirk Hose, Anja Seckinger, Els Van Valckenborgh, Elin… , 2015. - 16 S.
In: OncoTarget, ISSN 1949-2553. 6(2015), 5, Seite 3319-3334
DOI: 10.18632/oncotarget.3207
Bolomsky, Arnold: Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma / Arnold Bolomsky, Dirk Hose, Martin Schreder, Anja Seckinger, Susanne Lipp, Bernard Klein, Daniel Hei… , 08 February 2015. - 14 S.
In: Journal of hematology & oncology, ISSN 1756-8722. 8(2015)
DOI: 10.1186/s13045-014-0105-1
Bochtler, Tilmann: Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimens / Tilmann Bochtler, Ute Hegenbart, Christina Kunz, Martin Granzow, Axel Benner, Anja Seckinger, Christ… , 16 March 2015. - 8 S.
In: Journal of clinical oncology, ISSN 1527-7755. 33(2015), 12, Seite 1371-1378
DOI: 10.1200/JCO.2014.57.4947
Merz, Maximilian: Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma : an interim analysis from the prospective GMMG-MM5 trial / Maximilian Merz, Hans Salwender, Mathias Haenel, Elias K. Mai, Uta Bertsch, Christina Kunz, Thomas H… , July 2015. - 6 S.
In: Haematologica, ISSN 1592-8721. 100(2015), 7, Seite 964-969
DOI: 10.3324/haematol.2015.124347
Clemens, Jannick: Cellular uptake kinetics of bortezomib in relation to efficacy in myeloma cells and the influence of drug transporters / Jannick Clemens, Anja Seckinger, Dirk Hose, Dirk Theile, Magdalena Longo, Walter Emil Haefeli, Jürge… , 2015. - 11 S.
In: Cancer chemotherapy and pharmacology, ISSN 1432-0843. 75(2015), 2, Seite 281-291
DOI: 10.1007/s00280-014-2643-1
Striegler, Christin: Dendritic glycopolymer as drug delivery system for proteasome inhibitor bortezomib in a calcium phosphate bone cement : first steps toward a local therapy of osteolytic bone lesions / Christin Striegler, Matthias Schumacher, Christiane Effenberg, Martin Müller, Anja Seckinger, Reinha… , September 2015. - 13 S.
In: Macromolecular bioscience, ISSN 1616-5195. 15(2015), 9, Seite 1283-1295
DOI: 10.1002/mabi.201500085
Waizenegger, Jonas S.: Role of growth arrest-specific gene 6-Mer axis in multiple myeloma / JS Waizenegger, I Ben-Batalla, N Weinhold, T Meissner, M Wroblewski, M Janning, K Riecken, M Binder,… , 2015. - 10 S.
In: Leukemia, ISSN 1476-5551. 29(2015), 3, Seite 696-704
DOI: 10.1038/leu.2014.236
Seckinger, Anja: miRNAs in multiple myeloma : a survival relevant complex regulator of gene expression / Anja Seckinger, Tobias Meißner, Jérôme Moreaux, Vladimir Benes, Jens Hillengass, Mirco Castoldi, Jür… , 17 November 2015. - 19 S.
In: OncoTarget, ISSN 1949-2553. 6(2015), 36, Seite 39165-39183
DOI: 10.18632/oncotarget.5381
Meißner, Tobias: Profound impact of sample processing delay on gene expression of multiple myeloma plasma cells / Tobias Meißner, Anja Seckinger, Kari Hemminki, Uta Bertsch, Asta Försti, Mathias Hänel, Jan Duering,… . -
London: BioMed Central, 2016. - 1 Online-Ressource (8 Seiten)
DOI: 10.1186/s12920-015-0161-6
Mai, Elias K.: Phase III trial of bortezomib, cyclophosphamide, dexamethasone (VCD) versus bortezomib, doxorubicin, dexamethasone (PAd) in newly-diagnosed myeloma / E. K. Mai, U. Bertsch, J. Dürig, C. Kunz, M. Haenel, I. W. Blau, M. Munder, A. Jauch, B. Schurich, T… , 2015
In: Leukemia, ISSN 1476-5551. 29(2015), 8, Seite 1721-1729
DOI: 10.1038/leu.2015.80
Wagner, Verena: Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1 / Verena Wagner, Dirk Hose, Anja Seckinger, Ludmila Weiz, Tobias Meißner, Thiery Rème, Iris Breitkreut… , September 26, 2014. - 14 S.
In: OncoTarget, ISSN 1949-2553. 5(2014), 21, Seite 10237-10250
DOI: 10.18632/oncotarget.2529
Hassen, Wafa: Drug metabolism and clearance system in tumor cells of patients with multiple myeloma / Wafa Hassen, Alboukadel Kassambara, Thierry Reme, Surinder Sahota, Anja Seckinger, Laure Vincent, Gu… , 2015. - 17 S.
In: OncoTarget, ISSN 1949-2553. 6(2015), 8, Seite 6431-6447
DOI: 10.18632/oncotarget.3237
Dettmer, Susan: Fetal calf sera can distort cell-based luminescent proteasome assays through heat-resistant chymotrypsin-like activity / Susan Dettmer, Dirk Theile, Anja Seckinger, Jürgen Burhenne, Johanna Weiss, 2015. - 3 S.
In: Analytical biochemistry, ISSN 1096-0309. 471(2015), Seite 23-25
DOI: 10.1016/j.ab.2014.10.019
Clemens, Jannick: Stability of the proteasome inhibitor bortezomib in cell based assays determined by ultra-high performance liquid chromatography coupled to tandem mass spectrometry / Jannick Clemens, Magdalena Longo, Anja Seckinger, Dirk Hose, Walter Emil Haefeli, Johanna Weiss, Jür… , 6 June 2014. - 11 S.
In: Journal of chromatography, ISSN 1873-3778. 1345(2014), Seite 128-138
DOI: 10.1016/j.chroma.2014.04.024
Hose, Dirk: Biologie des multiplen Myeloms / D. Hose, A. Seckinger. - 9 S.
In: Der Onkologe, ISSN 1433-0415. 20(2014), 3, S. 208-216
DOI: 10.1007/s00761-013-2568-z
Bochtler, Tilmann: Gain of chromosome 1q21 is an independent adverse prognostic factor in light chain amyloidosis patients treated with melphalan/dexamethasone / Tilmann Bochtler, Ute Hegenbart, Christina Kunz, Axel Benner, Anja Seckinger, Sascha Dietrich, Marti… , 2014. - 9 S.
In: Amyloid, ISSN 1744-2818. 21(2014), 1, Seite 9-17
DOI: 10.3109/13506129.2013.854766
Seckinger, Anja: Interaktion zwischen Myelomzellen und Knochengewebe / A. Seckinger, D. Hose. - 6 S.
In: Der Radiologe, ISSN 1432-2102. 54(2014), 6, S. 545-550
DOI: 10.1007/s00117-013-2626-y
Maes, Ken: The in vivo transcriptional response towards epigenetic modulating agents in multiple myeloma / Ken Maes, Eva De Smedt, Kassambara Alboukadel, Dirk Hose, Anja Seckinger, Els Van Valckenborgh, Elin… , 2014. - 1 S.
In: Blood, ISSN 1528-0020. 124(2014,21) Artikel-Nr. 72054, 1 S.
Hájek, Roman: Prediction of progression of smouldering into therapy requiring multiple myeloma by easily accessible clinical factors [in 527 patients] / Roman Hajek, Viera Sandecka, Anja Seckinger, Ivan Spicka, Vlastimil Scudla, Evzen Gregora, Jakub Rad… , 2014. - 1 S.
In: Blood, ISSN 1528-0020. 124(2014,21) Artikel-Nr. 2071, 1 S.
Neben, Kai: Progression in smoldering myeloma is independently determined by the chromosomal abnormalities del(17p), t(4;14), gain 1q, hyperdiploidy, and tumor load / Kai Neben, Anna Jauch, Thomas Hielscher, Jens Hillengass, Nicola Lehners, Anja Seckinger, Martin Gra… , October 21, 2013. - 9 S.
In: Journal of clinical oncology, ISSN 1527-7755. 31(2013), 34, Seite 4325-4332
DOI: 10.1200/JCO.2012.48.4923
Witzens-Harig, Mathias: Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6 / Mathias Witzens-Harig, Dirk Hose, Simone Jünger, Christina Pfirschke, Nisit Khandelwal, Ludmila Uman… , April 19, 2013. - 11 S.
In: Blood, ISSN 1528-0020. 121(2013), 22, Seite 4493-4503
DOI: 10.1182/blood-2012-05-429415
Möhler, Thomas: The glycome of normal and malignant plasma cells / Thomas M. Moehler, Anja Seckinger, Dirk Hose, Mindaugas Andrulis, Jèrôme Moreaux, Thomas Hielscher, … , December 26, 2013. - 13 S.
In: PLOS ONE, ISSN 1932-6203. 8(2013), 12, Artikel-ID e83719, Seite 1-13
DOI: 10.1371/journal.pone.0083719
Seckinger, Anja: Clinical and prognostic role of annexin A2 in multiple myeloma. / Anja Seckinger, Tobias Meiβner, Jérôme Moreaux, Daniela Depeweg, Jens Hillengass, Katja Hose, Thierr… . - 8 S.
In: Blood, ISSN 1528-0020. 120(2012), 5, S. 1087-94
DOI: 10.1182/blood-2012-03-415588
Klein, Ulrike: Chromosomal aberrations +1q21 and del(17p13) predict survival in patients with recurrent multiple myeloma treated with lenalidomide and dexamethasone / Ulrike Klein, Anna Jauch, Thomas Hielscher, Jens Hillengass, Marc S. Raab, Anja Seckinger, Dirk Hose… , 2011. - 9 S.
In: Cancer, ISSN 1097-0142. 117(2011), 10, Seite 2136-2144
DOI: 10.1002/cncr.25775
Meißner, Tobias: Gene expression profiling in multiple myeloma - reporting of entities, risk, and targets in clinical routine / Tobias Meißner, Anja Seckinger, Thierry Rème, Thomas Hielscher, Thomas Möhler, Kai Neben, Hartmut Go… , November 30 2011. - 8 S.
In: Clinical cancer research, ISSN 1557-3265. 17(2011), 23, Seite 7240-7247
DOI: 10.1158/1078-0432.CCR-11-1628
Hose, Dirk: Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma / Dirk Hose, Thierry Rème, Thomas Hielscher, Jérôme Moreaux, Tobias Messner, Anja Seckinger, Axel Benn… , January, 2011. - 9 S.
In: Haematologica, the hematology journal, ISSN 1592-8721. 96(2011), 1, Seite 87-95
DOI: 10.3324/haematol.2010.030296
Bret, Caroline: Gene expression profile of ADAMs and ADAMTSs metalloproteinases in normal and malignant plasma cells and in the bone marrow environment / Caroline Bret, Dirk Hose, Thierry Reme, Alboukadel Kassambara, Anja Seckinger, Tobias Meißner, Jean-… , 11 February 2011. - 20 S.
In: Experimental hematology, ISSN 1873-2399. 39(2011), 5, Seite 546-557.e8
DOI: 10.1016/j.exphem.2011.02.002
Bochtler, Tilmann: Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14) / Tilmann Bochtler, Ute Hegenbart, Christiane Heiss, Axel Benner, Marion Moos, Anja Seckinger, Stephan… , April 7, 2011. - 7 S.
In: Blood, ISSN 1528-0020. 117(2011), 14, Seite 3809-3815
DOI: 10.1182/blood-2010-02-268987
Fuhler, Gwenny M.: Bone marrow stromal cell interaction reduces Syndecan-1 expression and induces kinomic changes in myeloma cells / Gwenny M. Fuhler, Mirjam Baanstra, Daniel Chesik, Rajesh Somasundaram, Anja Seckinger, Dirk Hose, Ma… , 20 March 2010. - 13 S. : Illustrationen
In: Experimental cell research, ISSN 1090-2422. 316(2010), 11 vom: Juli, Seite 1816-1828
DOI: 10.1016/j.yexcr.2010.03.013
Neben, Kai: Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantation / Kai Neben, Anna Jauch, Uta Bertsch, Christiane Heiss, Thomas Hielscher, Anja Seckinger, Tina Mors, N… , 2010 Jul. - 8 S. : Diagramme
In: Haematologica, the hematology journal, ISSN 1592-8721. 95(2010), 7, Seite 1150-1157
DOI: 10.3324/haematol.2009.016436
Hose, Dirk: Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma / Dirk Hose, Thierry Rème, Tobias Meissner, Jérôme Moreaux, Anja Seckinger, Joe Lewis, Vladimir Benes,… , [April 30 2009]. - 10 S. : Illustrationen
In: Blood, ISSN 1528-0020. 113(2009), 18, Seite 4331-4340
DOI: 10.1182/blood-2008-09-178350
Sprynski, Anne Catherine: The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor / Anne Catherine Sprynski, Dirk Hose, Laurent Caillot, Thierry Réme, John D., Jr Shaughnessy, Bart Bar… , [May 7 2009]. - 13 S. : Illustrationen
In: Blood, ISSN 1528-0020. 113(2009), 19, Seite 4614-4626
DOI: 10.1182/blood-2008-07-170464
Hose, Dirk: Induction of angiogenesis by normal and malignant plasma cells / Dirk Hose, Jérôme Moreaux, Tobias Meissner, Anja Seckinger, Hartmut Goldschmidt, Axel Benner, Karène… , [2 July 2009]. - 16 S.
In: Blood, ISSN 1528-0020. 114(2009), 1, Seite 128-143
DOI: 10.1182/blood-2008-10-184226
Seckinger, Anja: Bone morphogenic protein 6 : a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis / A. Seckinger, T. Meißner, J. Moreaux, H. Goldschmidt, G. M. Fuhler, A. Benner, M. Hundemer, T. Rème,… , 31 August 2009. - 14 S.
In: Oncogene, ISSN 1476-5594. 28(2009), 44, Seite 3866-3879
DOI: 10.1038/onc.2009.257
Seckinger, Anja: Molekulare und funktionelle Untersuchung adulter mesenchymaler Stammzellen aus dem Knochenmark / vorgelegt von Anja Seckinger, 2007 [ersch.] 2008. - IX, 142 Bl. : Ill., graph. Darst.
Gottschling, Sandra: Human mesenchymal stromal cells regulate initial self-renewing divisions of hematopoietic progenitor cells by a β1-integrin-dependent mechanism / Sandra Gottschling, Rainer Saffrich, Anja Seckinger, Ulf Krause, Kerstin Horsch, Katrin Miesala, Ant… , [2007]. - 9 S. : Illustrationen
In: Stem cells, ISSN 1549-4918. 25(2007), 3, Seite 798-806
DOI: 10.1634/stemcells.2006-0513
Krause, Ulf: Intravenous delivery of autologous mesenchymal stem cells limits infarct size and improves left ventricular function in the infarcted porcine heart / Ulf Krause, Christoph Harter, Anja Seckinger, David Wolf, Adrian Reinhard, Florian Bea, Thomas Dengl… , 11 Mar 2007. - 8 S.
In: Stem Cells and Development, ISSN 1557-8534. 16(2007), 1, Seite 31-38
DOI: 10.1089/scd.2006.0089
Schweizer, Patrick Alexander: Atrial-radiofrequency catheter ablation mediated targeting of mesenchymal stromal cells / Patrick A. Schweizer, Ulf Krause, Ruediger Becker, Anja Seckinger, Alexander Bauer, Cornelia Hardt, … , [2007]. - 6 S. : Illustrationen
In: Stem cells, ISSN 1549-4918. 25(2007), 6, Seite 1546-1551
DOI: 10.1634/stemcells.2006-0682
Gottschling, Sandra: Primitive and committed human hematopoietic progenitor cells interact with primary murine neural cells and are induced to undergo self-renewing cell divisions / Sandra Gottschling, Volker Eckstein, Rainer Saffrich, Alexandr Jonáš, Markus Uhrig, Ulf Krause, Anja… , [December 2007]. - 14 S. : Illustrationen
In: Experimental hematology, ISSN 1873-2399. 35(2007), 12, Seite 1858-1871
DOI: 10.1016/j.exphem.2007.06.013
Wuchter, Patrick: Processus and recessus adhaerentes : giant adherens cell junction systems connect and attract human mesenchymal stem cells / Patrick Wuchter, Judit Boda-Heggemann, Beate K. Straub, Christine Grund, Caecilia Kuhn, Ulf Krause, … , 20 March 2007. - 16 S. : Illustrationen
In: Cell & tissue research, ISSN 1432-0878. 328(2007), 3, Seite 499-514
DOI: 10.1007/s00441-007-0379-5
Wagner, Wolfgang: The heterogeneity of human mesenchymal stem cell preparations : evidence from simultaneous analysis of proteomes and transcriptomes / Wolfgang Wagner, Robert E. Feldmann, Anja Seckinger, Martin H. Maurer, Frederik Wein, Jonathon Blake… , [2006]. - 13 S.
In: Experimental hematology, ISSN 1873-2399. 34(2006), 4 vom: Apr., Seite 536-548
DOI: 10.1016/j.exphem.2006.01.002
Niemeyer, Philipp: Evaluation of mineralized collagen and α-tricalcium phosphate as scaffolds for tissue engineering of bone using human mesenchymal stem cells / Philipp Niemeyer, Ulf Krause, Jörg Fellenberg, Philip Kasten, Anja Seckinger, Anthony D. Ho, Hans-Ge… , [August 2004]. - 11 S.
In: Cells tissues organs, ISSN 1422-6421. 177(2004), 2, Seite 68-78
DOI: 10.1159/000079182

IDs

GND:

134177371

Links

Seckinger, Anja in ...

Export publication list

heiBIB

Please contact biblio@ub.uni-heidelberg.de in case of any errors or omissions.

Information concerning heiBIB (including embedding the publication list in existing websites).

Impressum / Datenschutz Design